688356 Stock Overview
Develops and manufactures polyethylene glycol derivative (PEG) products in China.
| Snowflake Score | |
|---|---|
| Valuation | 0/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 2/6 |
Jenkem Technology Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥69.72 |
| 52 Week High | CN¥135.85 |
| 52 Week Low | CN¥60.71 |
| Beta | 0.71 |
| 1 Month Change | -7.89% |
| 3 Month Change | -12.14% |
| 1 Year Change | -41.26% |
| 3 Year Change | -67.11% |
| 5 Year Change | n/a |
| Change since IPO | -49.05% |
Recent News & Updates
Shareholder Returns
| 688356 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -6.5% | -2.3% | 1.3% |
| 1Y | -41.3% | -11.4% | -9.1% |
Return vs Industry: 688356 underperformed the CN Pharmaceuticals industry which returned -11.4% over the past year.
Return vs Market: 688356 underperformed the CN Market which returned -9.1% over the past year.
Price Volatility
| 688356 volatility | |
|---|---|
| 688356 Average Weekly Movement | 8.8% |
| Pharmaceuticals Industry Average Movement | 5.8% |
| Market Average Movement | 7.2% |
| 10% most volatile stocks in CN Market | 10.6% |
| 10% least volatile stocks in CN Market | 4.2% |
Stable Share Price: 688356's share price has been volatile over the past 3 months.
Volatility Over Time: 688356's weekly volatility (9%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 280 | Xuan Zhao | www.jenkem.com |
Jenkem Technology Co., Ltd. develops and manufactures polyethylene glycol derivative (PEG) products in China. The company offers branched, linear, homobifunctional, heterobifunctional, multi-arm homofunctional, multi-arm heterofunctional, monodisperse / discrete, and biodegradable PEG products. It also provides PEGylation services and testing services for peptides, proteins, enzymes, small molecules, and RNA.
Jenkem Technology Co., Ltd. Fundamentals Summary
| 688356 fundamental statistics | |
|---|---|
| Market cap | CN¥4.41b |
| Earnings (TTM) | CN¥90.08m |
| Revenue (TTM) | CN¥271.04m |
46.9x
P/E Ratio15.6x
P/S RatioIs 688356 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688356 income statement (TTM) | |
|---|---|
| Revenue | CN¥271.04m |
| Cost of Revenue | CN¥8.56m |
| Gross Profit | CN¥262.48m |
| Other Expenses | CN¥172.40m |
| Earnings | CN¥90.08m |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.49 |
| Gross Margin | 96.84% |
| Net Profit Margin | 33.24% |
| Debt/Equity Ratio | 0.5% |
How did 688356 perform over the long term?
See historical performance and comparison